<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03547362</url>
  </required_header>
  <id_info>
    <org_study_id>NL65184.072.18</org_study_id>
    <nct_id>NCT03547362</nct_id>
  </id_info>
  <brief_title>Real-time Amino Acid Profiling</brief_title>
  <acronym>RAP</acronym>
  <official_title>Real-time Amino Acid Profiling</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NIZO Food Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>FrieslandCampina</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>NIZO Food Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study was designed to obtain information about the effect of new combinations of dairy
      proteins, in small servings with high protein concentrations, on postprandial amino acid
      kinetics in blood in an older population.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 30, 2018</start_date>
  <completion_date type="Actual">July 5, 2018</completion_date>
  <primary_completion_date type="Actual">July 5, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>The study is designed as a randomized, single-blinded within-subject (cross-over) trial in which a group of 12 subjects receive 6 different dairy products.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postprandial serum amino acid concentration</measure>
    <time_frame>0-300 min after consumption</time_frame>
    <description>Blood amino acid concentrations (mmol/L) before and at 13 time points (up till 5 hours) after consumption of the dairy products.</description>
  </primary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Protein Digestion Kinetics</condition>
  <arm_group>
    <arm_group_label>Casein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single oral administration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dairy protein blend 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>single oral administration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Whey protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single oral administration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dairy protein blend 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single oral administration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dairy protein blend 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single oral administration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dairy protein blend 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single oral administration</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Casein</intervention_name>
    <description>See arm description</description>
    <arm_group_label>Casein</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Dairy protein blend 1</intervention_name>
    <description>See arm description</description>
    <arm_group_label>Dairy protein blend 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Whey protein</intervention_name>
    <description>See arm description</description>
    <arm_group_label>Whey protein</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Dairy protein blend 2</intervention_name>
    <description>See arm description</description>
    <arm_group_label>Dairy protein blend 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Dairy protein blend 3</intervention_name>
    <description>See arm description</description>
    <arm_group_label>Dairy protein blend 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Dairy protein blend 4</intervention_name>
    <description>See arm description</description>
    <arm_group_label>Dairy protein blend 4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥65 and ≤80

          -  BMI ≥20 and ≤32 kg/m2

          -  Non-smoking

          -  Healthy as assessed by the NIZO lifestyle and health questionnaire (&quot;Verklaring
             leefgewoonten en gezondheid&quot;) and according to the judgment of the study physician.

          -  Regular and normal Dutch eating habits as assessed by the NIZO lifestyle and health
             questionnaire (3 main meals per day)

          -  Veins suitable for cannulation (blood sampling)

          -  Voluntary participation

          -  Having given written informed consent

          -  Willing to comply with study procedures

          -  Accept use of all encoded data, including publication, and the confidential use and
             storage of all data for 15 years.

          -  Accept disclosure of the financial benefit of participation in the study to the
             authorities concerned

        Exclusion Criteria:

          -  Participation in any clinical trial including blood sampling and/or administration of
             substances up to 30 days before day 1 of this study

          -  Having a history of medical or surgical events that may significantly affect the study
             outcome, including: Inflammatory bowel disease, hepatitis, pancreatitis, ulcers,
             gastrointestinal or rectal bleeding; major gastrointestinal tract surgery such as
             gastrectomy, gastroenterostomy, or bowel resection; known or suspected
             gastrointestinal disorders, colon or GI tract cancer

          -  Use of the following medication: glucose lowering drugs, insulin; medication that may
             impact gastric emptying (e.g. gastric acid inhibitors or laxatives)

          -  Diagnosed with diabetes, being treated for high blood glucose or increased fasting
             blood glucose (&gt; 7 mmol/l in finger prick blood) as assessed during screening visit

          -  For men: Hb &lt;8,5 mmol/l as assessed during screening visit; for women: Hb &lt;7,5 mmol/l.

          -  Use of protein supplements

          -  Mental status that is incompatible with the proper conduct of the study

          -  A self-reported reported food allergy or sensitivity to dairy ingredients

          -  Alcohol consumption for men &gt; 28 units/week and &gt;4/day; for women: &gt;21 units/week and
             &gt;3/day

          -  Reported unexpected weight loss or weight gain of &gt; 3 kg in the month prior to
             pre-study screening, or intention to lose weight during the study period

          -  Reported slimming or medically prescribed diet

          -  Recent blood donation (&lt;1 month prior to Day 01 of the study)

          -  Not willing to give up blood donation during the study

          -  Personnel of NIZO food research and FrieslandCampina, their partner and their first
             and second degree relatives

          -  Not having a general practitioner

          -  Not willing to accept information-transfer concerning participation in the study, or
             information regarding his or her health, like laboratory results and eventual adverse
             events to and from his general practitioner
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Melle van Schaik</last_name>
    <role>Study Director</role>
    <affiliation>NIZO Food Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NIZO Food Research</name>
      <address>
        <city>Ede</city>
        <state>Gelderland</state>
        <zip>6718ZB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>April 20, 2018</study_first_submitted>
  <study_first_submitted_qc>May 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 6, 2018</study_first_posted>
  <last_update_submitted>July 10, 2018</last_update_submitted>
  <last_update_submitted_qc>July 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Amino acids</keyword>
  <keyword>Dairy proteins</keyword>
  <keyword>Postprandial</keyword>
  <keyword>Older adults</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Caseins</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

